Abstract
Dormancy in mycobacteria is defined as a stable but reversible non-replicating state in response to stresses. In Mycobacterium tuberculosis, an important human pathogen, this state is responsible for latent Tuberculosis. The current chemotherapy to defeat Tuberculosis while effective in killing growing tubercle bacilli is largely ineffective in killing dormant bacilli. For this reason there is a recent interest to develop new drugs against this disease in the latent form. To this aim, the knowledge of the molecular basis of bacterial resuscitation from dormancy is necessary and of paramount importance. This review summarizes the current knowledge on the complex mechanism of exit from mycobacterial dormancy; the main molecular players responsible for mycobacterial resuscitation from dormancy are described and their role is discussed from a structural perspective.
Keywords: Dormancy, mycobacteria, resuscitation, structure.
Current Medicinal Chemistry
Title:Exit from Mycobacterial Dormancy: A Structural Perspective
Volume: 22 Issue: 14
Author(s): Flavia Squeglia, Alessia Ruggiero and Rita Berisio
Affiliation:
Keywords: Dormancy, mycobacteria, resuscitation, structure.
Abstract: Dormancy in mycobacteria is defined as a stable but reversible non-replicating state in response to stresses. In Mycobacterium tuberculosis, an important human pathogen, this state is responsible for latent Tuberculosis. The current chemotherapy to defeat Tuberculosis while effective in killing growing tubercle bacilli is largely ineffective in killing dormant bacilli. For this reason there is a recent interest to develop new drugs against this disease in the latent form. To this aim, the knowledge of the molecular basis of bacterial resuscitation from dormancy is necessary and of paramount importance. This review summarizes the current knowledge on the complex mechanism of exit from mycobacterial dormancy; the main molecular players responsible for mycobacterial resuscitation from dormancy are described and their role is discussed from a structural perspective.
Export Options
About this article
Cite this article as:
Squeglia Flavia, Ruggiero Alessia and Berisio Rita, Exit from Mycobacterial Dormancy: A Structural Perspective, Current Medicinal Chemistry 2015; 22 (14) . https://dx.doi.org/10.2174/0929867322666150209153027
DOI https://dx.doi.org/10.2174/0929867322666150209153027 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Estrogen Receptor Beta (ERβ) Expression in Different Subtypes of Malignant
Pleural Mesothelioma
Current Respiratory Medicine Reviews Riboflavin Analogs as Antiinfectives: Occurrence, Mode of Action, Metabolism and Resistance
Current Pharmaceutical Design Constructive Personalized Medicine: The Potential Integration of Synthetic Biology and Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Identification of Active Phytochemical from Traditional Herbal Knowledge-base Targeting Pantothenate Synthetase for Anti-tuberculosis Therapy
Letters in Drug Design & Discovery 3D QSAR Analysis of 2-(Substituted Aryl)-Thiazolidine-4-Carboxamides as Potent Antitubercular Agents
Current Computer-Aided Drug Design Morbidity and Mortality Associated with Pharmacotherapy. Evolution and Current Concept of Drug-Related Problems
Current Pharmaceutical Design Key Sites for P2X Receptor Function and Multimerization: Overview of Mutagenesis Studies on a Structural Basis
Current Medicinal Chemistry Quinolones in the Search for New Anticancer Agents
Current Pharmaceutical Design Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Focus on Virus Induced Exacerbations
Current Pharmaceutical Design Anti-Tuberculosis
Current Bioactive Compounds Microemulsions and Nanoemulsions for Targeted Drug Delivery to the Brain
Current Nanoscience Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health
Current Pharmacogenomics and Personalized Medicine In Vitro Cytochrome P450 Inhibition and Induction
Current Drug Metabolism Bombacaceae Between the Ethnomedical Uses and Pharmacological Evidences: A Review
The Natural Products Journal Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Hybrid Drugs as Potential Combatants Against Drug-Resistant Microbes: A Review
Current Topics in Medicinal Chemistry Preface
Current Medical Imaging Pulmonary Drug Delivery: A Role for Polymeric Nanoparticles?
Current Topics in Medicinal Chemistry Pregnane X Receptor (PXR) at the Crossroads of Human Metabolism and Disease
Current Drug Metabolism FDG-PET Imaging in Sarcoidosis
Current Medical Imaging